Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions.

45 It is a common condition, affecting approximately 1% of the population worldwide, 46 and showing an increasing trend over time. 47 The burden experienced by patients with CSU can be considerable, with challenges such as sleep deprivation, sexual dysfunction, limitations on daily life, and reduced performance at work or school all affecting health‐related quality of life. 46 A lack of understanding of unde

also in 63,971 other papers